There have been approximately only 800 patients with diagnosis of SAS (sleep apnea syndrome) by polysomnography over recent several years in 25 institutions in Japan. This was obtained by the meeting for sleep disordered breathing found recently. In contrast, in North America some a hundred thausand patients with SAS are estimated, and about a half of them have got treatment for SAS with overt clinical symptoms annually. There is tremendous difference of the incidence between two areas, and this may attribute to relatively unawareness of SAS in our country. In this review, in addition to this syndrome's outline, we also describe the most important issues of SAS, among which are as follows.
First, SAS has been diagnosed by using Guilleminault's criteria more than a decade in almost all hospitals anywhere in the world. However, senile subjects tend to be overdiagnosed as having SAS, because apnea number per unit time steeply increases with age especially in case of patients, whose ages are more than 60 year-old. To avoid this, more appropriate criteria based on necessity of treatment should be established as soon as possible.
Secondly, recent papers have observed the similarity of the initializing mechanism between in OSA (obstructive sleep apnea) and CSA (central sleep apnea), both of which had considered as having distinct mechanisms to elicit each type of apnea. Despite this similarity in mechanism between OSA and CSA, we do not know why one patient proceed to OSA and another patient get CSA. Accordingly more detail mechanism should be elucidated intensively.
Thirdly, although numerous therapeutic approaches have been used for the treatment of SAS over a couple of decades, all approaches without tracheostomy and nasal CPAP could not have shown their satisfactory effects on SAS. For instance, effects of drugs which stimulate ventilation (e. g. progesterone derivatives, acetazolamide), have been found unsatisfactory on SAS. On the other hand, tracheostomy and nasal CPAP have been established as the best approach to treat them. And in these days, nasal CPAP has been thought as the best for SAS patients from cosmetic point of view and its relatively safety compared with tracheostomy. However, the long-term effect of nasal CPAP should be confirmed.
Finally, although a number of facts concerning about SAS have been elucidated in recent years, there are many things related to SAS still remain unknown. Therefore, as we have to evaluate SAS patients throughly and have to decide precisely whether patients should be treated or not, we hope this review can help you to recognize how serious the complication of SAS could be.
抄録全体を表示